Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Affymax reports positive results from Phase II anemia study
In the Phase II study, 182 patients using Hematide once every four weeks for up to 23 months successfully maintained average hemoglobin levels within an 11 to 12g/dl
In the Phase II study, 182 patients using Hematide once every four weeks for up to 23 months successfully maintained average hemoglobin levels within an 11 to 12g/dl
Under the terms of the agreement, Allergan paid Spectrum $41.5 million within 10 days of closing and will make additional payments of up to $304 million based on
Aldagen will be collaborating with Martha O’Donnell, a professor of physiology and membrane biology, and with Jan Nolta, director of the new UC Davis Institute for Regenerative Cures
The new headquarters will manage the company’s commercial and pharmaceutical development services sales, marketing and customer support activities in Europe. Certain support functions will be managed in Zug
The company has also reduced the number of US headquarters from two to one and moved its headquarters to Research Triangle Park, North Carolina. The initiative was undertaken
The investment is expected to create close to 500 new jobs in Tianjin. It is said to be one of the largest investments in Novo Nordisk’s history, and
All three trials were designed to evaluate the efficacy, safety and tolerability of low doses of AEGR-733 alone and in combination with other lipid lowering agents such as
The Noveon is a light-based system that targets the elimination of bacterial and fungal infections through a unique near-infrared photo-inactivation effect, while preserving healthy tissue and promoting recovery.
Saturn is a placebo-controlled, randomized, double-blind, Phase III study conducted by Roche that enrolled 889 patients with advanced non-small cell lung cancer (NSCLC) at approximately 160 sites worldwide.
Poniard’s randomized, open-label, dose-ranging Phase I study was conducted at clinical sites in the US. The trial compared the bioavailability, pharmacokinetics, pharmacodynamics and safety of picoplatin administered orally